Laird Norton Wetherby Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Buy |
|
|||||
|
2024
Q4 | $894K | Sell |
|
|||||
|
2024
Q3 | $1.57M | Sell |
|
|||||
|
2024
Q2 | $1.84M | Sell |
|
|||||
|
2024
Q1 | $2.31M | Buy |
|
|||||
|
2023
Q4 | $1.91M | Buy |
|
|||||
|
2023
Q3 | $1.73M | Buy |
|
|||||
|
2023
Q2 | $1.61M | Buy |
|
|||||
|
2023
Q1 | $1.42M | Buy |
|
|||||
|
2022
Q4 | $1.27M | Buy |
|
|||||
|
2022
Q3 | $584K | Sell |
|
|||||
|
2022
Q2 | $1.4M | Sell |
|
|||||
|
2022
Q1 | $1.48M | Buy |
|
|||||
|
2021
Q4 | $1.49M | Buy |
|
|||||
|
2021
Q3 | $1.1M | Buy |
|
|||||
|
2021
Q2 | $939K | Buy |
|
|||||
|
2021
Q1 | $778K | Sell |
|
|||||
|
2020
Q4 | $893K | Sell |
|
|||||
|
2020
Q3 | $1.34M | Sell |
|
|||||
|
2020
Q2 | $1.63M | Buy |
|
|||||
|
2020
Q1 | $1.21M | Sell |
|
|||||
|
2019
Q4 | $2.02M | Sell |
|
|||||
|
2019
Q3 | $1.89M | Buy |
|
|||||
|
2019
Q2 | $1.62M | Buy |
|
|||||
|
2019
Q1 | $1.63M | Buy |
|
|||||
|
2018
Q4 | $1.25M | Sell |
|
|||||
|
2018
Q3 | $1.48M | Buy |
|
|||||
|
2018
Q2 | $1.4M | Buy |
|
|||||
|
2018
Q1 | $1.07M | Buy |
|
|||||
|
2017
Q4 | $604K | Sell |
|
|||||
|
2017
Q3 | $1.05M | Buy |
|
|||||
|
2017
Q2 | $1.11M | Buy |
|
|||||
|
2017
Q1 | $1.03M | Buy |
|
|||||
|
2016
Q4 | $611K | Sell |
|
|||||
|
2016
Q3 | $1.13M | Buy |
|
|||||
|
2016
Q2 | $1.09M | Sell |
|
|||||
|
2016
Q1 | $1.03M | Buy |
|
|||||
|
2015
Q4 | $965K | Buy |
|
|||||
|
2015
Q3 | $810K | Buy |
|
|||||
|
2015
Q2 | $714K | Sell |
|
|||||
|
2015
Q1 | $938K | Buy |
|
|||||
|
2014
Q4 | $710K | Sell |
|
|||||
|
2014
Q3 | $822K | Sell |
|
|||||
|
2014
Q2 | $1.01M | Buy |
|
|||||
|
2014
Q1 | $978K | Buy |
|
|||||
|
2013
Q4 | $942K | Buy |
|
|||||
|
2013
Q3 | $879K | Buy |
|
|||||
|
2013
Q2 | $820K | Buy |
|